Log In
BCIQ
Print this Print this
 

LongAte, NecLip-pdFVIII

  Manage Alerts
Collapse Summary General Information
Company Recoly N.V.
DescriptionRecombinant Factor VIII (rFVIII) formulated with NecLip liposomes
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentApproved
Standard IndicationHemophilia
Indication DetailsTreat hemophilia A
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today